X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Tilidine is a WHO-step-II opioid painkiller and in Germany almost always available in a fixed combination with naloxone, known as Valoron N. About 4 million pain patients in Germany receive opioids (a German figure), many of them tilidine as an entry point before stronger substances. Unlike the prolonged-release tablets, which are not controlled drugs, the fast-acting drops have been subject to Germany's controlled-drugs law since 2013 — misuse had increased above all among adolescents. (Note: tilidine is a continental-European opioid and is not marketed in the UK or US.)
See more detail.gif)
Never combine tilidine with alcohol or sedatives — mortal danger through respiratory depression. After prolonged use, do not stop abruptly. With very slow breathing, unrousability or blue lips, call the emergency services immediately (112; or 999/112 in the UK). Last updated: May 2026.
Tilidine is an opioid painkiller of WHO step II, in Germany almost always in a fixed combination with naloxone. Below are the key facts for quick orientation; the individual points are explained in detail in the following chapters.
| Property | Details |
|---|---|
| Active substance | Tilidine (a prodrug, active as nortilidine) - usually with naloxone |
| Trade names | Valoron N, tilidine-naloxone generics - drops and prolonged-release tablets |
| ATC code | N02AX51 - opioids in combination |
| WHO step | II - a moderately strong opioid |
| Mechanism of action | Activation of μ-opioid receptors (nortilidine); the naloxone component blocks the high in case of misuse (i.v.) |
| Main indications | Moderate to severe pain when non-opioid painkillers are not enough |
| Usual dose | Prolonged-release tablets twice daily; drops as needed - individually by a doctor |
| Onset of action | Drops 10-30 min; prolonged-release tablets delayed over hours |
| Controlled-drug status | Drops subject to controlled-drug regulations (BtM) since 2013; prolonged-release tablets not subject to BtM |
| Most important risks | Respiratory depression (especially with alcohol/benzodiazepines), dependence, constipation |
| Antidote | Naloxone (also in the preparation, an emergency-doctor antidote) |
Tilidine is an opioid painkiller used for moderate to severe pain when weaker painkillers are not enough. It belongs to the weak to moderately strong opioids (WHO step II) and is offered in Germany almost always in a fixed combination with the active substance naloxone - known under the trade name Valoron N. This combination has an important safety reason, which we explain in detail.
Tilidine is an effective painkiller that is well controllable with correct use. In recent years, however, it has also gained sad notoriety through misuse - especially among young people and in certain scenes. This has led to stricter regulations and makes factual education about its effect, risks and safe use particularly important.
Like all opioids, tilidine can be addictive and dangerous in overdose - especially in combination with other depressant substances. At the same time, it is a valuable medicine for many pain patients. This article explains responsible use, without trivialising and without dramatising.
Tilidine itself is at first barely active - it is a so-called prodrug. Only in the liver is it converted into the actually active substance nortilidine. Nortilidine binds to the opioid receptors (especially μ-receptors) in the central nervous system and there dampens the perception and transmission of pain - similar to the body's own endorphins, only stronger.
This activation of the opioid receptors brings about the pain-relieving effect, but is also responsible for the typical opioid side effects: fatigue, constipation, nausea, and at high doses the dangerous respiratory depression. The potential for dependence also rests on the effect at these receptors - via the body's own reward system.
Tilidine is well absorbed after oral intake and converted in the liver to nortilidine. The effect of the drops sets in rapidly (within 10-30 minutes), that of the prolonged-release tablets delayed and evenly over hours. Metabolism via the liver also means: with severe liver dysfunction, the conversion to the active nortilidine can be impaired, which changes the effect.
A clever and important safety principle that distinguishes tilidine from other opioids. The combination partner naloxone is an opioid antagonist - it blocks the opioid receptors and cancels the opioid effect. Why combine a painkiller with its own antagonist? The answer lies in the different behaviour depending on the route of intake.
If tilidine/naloxone is swallowed as intended, the naloxone is almost completely broken down on the first liver passage (a strong first-pass effect) - it has practically no effect. The tilidine, on the other hand, is converted to the active nortilidine and can fully develop its pain-relieving effect. With intended use, the naloxone therefore does not interfere.
If, on the other hand, the medicine is injected for misuse (intravenously) to achieve a high, the naloxone bypasses the liver - and immediately blocks the opioid receptors. The hoped-for high fails to materialise, and in opioid-dependent people withdrawal can even be triggered. Even with massive oral overdose, naloxone can partly counteract.
This protection against misuse is the reason for the combination - it is intended to make intravenous misuse unattractive. Misuse cannot be completely prevented by this, however, which explains the additional regulatory measures (see the chapter on drops vs. tablets).
Tilidine is used for moderate to severe pain that cannot be adequately treated with non-opioid painkillers (such as ibuprofen, paracetamol, metamizole):
Tilidine sits on step II of the WHO step ladder of pain therapy - between the non-opioid painkillers (step I) and the strong opioids such as morphine (step III). It is often combined with non-opioid painkillers to attack at various points of pain development. The indication and dosing are determined by the doctor within a well-thought-out pain concept.
A central and safety-relevant difference with tilidine - the two dosage forms behave completely differently and are subject to different rules:
| Aspect | Tilidine drops | Tilidine prolonged-release tablets |
|---|---|---|
| Onset of action | Fast (10-30 min) | Slow, evenly over hours |
| Surge | Fast surge - a noticeable effect | No fast surge |
| Misuse potential | Higher | Lower |
| Legal status | Subject to controlled-drug regulations (BtM) since 2013 | Normal prescription (not BtM) |
| Indication | Acute pain peaks, as-needed medication | Long-term therapy of chronic pain |
| Advantages | Fast help with pain peaks | Even pain protection, lower misuse risk |
This distinction explains the different regulation: the fast-surging drops were made subject to controlled-drug regulations (BtM) in 2013, after their misuse - especially among young people - had increased. For the long-term therapy of chronic pain, the prolonged-release tablets are standard, because they act more evenly and have less misuse potential.
The dosing is always determined individually by the doctor - depending on the pain intensity, prior experience with opioids and general condition:
A central and serious topic with tilidine. Like all opioids, tilidine can cause physical and psychological dependence. The risk depends strongly on the dosage form, dose, duration and individual factors.
With correct use in pain therapy - especially with prolonged-release tablets and under medical supervision - the risk of dependence is manageable but present. With prolonged use, a physical habituation develops, so that withdrawal symptoms can occur on stopping (see the stopping chapter). This is not the same as an addiction, but requires a controlled tapering.
Tilidine - especially the drops - has in recent years gained sad notoriety through misuse, partly promoted by its portrayal in certain music and social media. The misuse aims at the depressant, euphoric or disinhibiting effect. The naloxone combination and the controlled-drug status of the drops are intended to counteract this.
With such signs, medical help is important - an opioid dependence is treatable, and acting early is decisive.
Tilidine has the typical opioid side effects. Common, especially at the start:
Particularly important - the constipation: unlike most other opioid side effects, the opioid-related constipation does not disappear through habituation. With prolonged use, an accompanying treatment (a high-fibre diet, drinking enough, laxatives prescribed by a doctor if necessary) is therefore important.
The most dangerous risk of all opioids - tilidine too. In overdose, opioids can dampen the breathing (respiratory depression) up to respiratory arrest. This is the most common reason for fatal opioid poisonings.
With intended use in pain therapy, the respiratory-depression risk is low - it becomes critical with overdose and dangerous combinations. That is precisely why the maximum dose and the alcohol ban are so important.
Tilidine has clinically very relevant interactions - especially with other depressant substances:
| Substance/category | Effect | Recommendation |
|---|---|---|
| Alcohol | Enhanced depression and respiratory depression | Strictly avoid - life-threatening |
| Benzodiazepines (diazepam, lorazepam, Tavor and others), Z-drugs (zolpidem) | Strongly increased respiratory-depression risk | A dangerous combination - only under strict indication |
| Other opioids | Additive effect, respiratory depression | Never without medical instruction |
| Sedating antidepressants (mirtazapine, tricyclics) | Enhanced depression | Caution, low doses |
| Antipsychotics | Enhanced sedation | Caution |
| Gabapentin, pregabalin | Increased respiratory-depression risk (BfArM warning) | Only under medical supervision |
| Buprenorphine, naltrexone (opioid antagonists) | Can cancel the tilidine effect or trigger withdrawal | Do not combine |
| Liver-enzyme-modifying medicines | Can change the conversion to nortilidine | Consult a doctor |
The combination with benzodiazepines is particularly critical and a common factor in opioid deaths. Before any new medication, consult a doctor/pharmacist. More under Interactions of medicines and Taking medicines correctly.
The danger is real and is often underestimated: while tilidine at a therapeutic dose alone is usually well tolerated, even a moderate amount of alcohol can dangerously enhance the depressant effect. This applies to all dosage forms. Throughout the entire tilidine therapy, alcohol should be consistently avoided - even small amounts.
After prolonged use, tilidine must not be stopped abruptly - the body has become accustomed to the opioid, and a sudden stop triggers a withdrawal syndrome:
Possible withdrawal symptoms: restlessness, anxiety, sleep disturbances, sweating, goosebumps, muscle and limb pain, abdominal cramps, diarrhoea, nausea, a racing heart, watering eyes and a runny nose, a strong craving. These are unpleasant but largely avoidable with controlled tapering.
The occurrence of withdrawal symptoms on abrupt stopping is an expression of the physical habituation and not a sign of moral failure. With planned tapering, stopping is well achievable.
| Observation | Frequency | Typical comment |
|---|---|---|
| Constipation as the main problem after weeks | Very common | "After 3 weeks of tilidine for back pain, the constipation was worse than the pain - my GP then prescribed a laxative alongside straight away." |
| Self-directed dose escalation with tolerance | Common | "I increased the dose myself because it no longer worked - instead of going to the doctor, which would have been much wiser." |
| Respiratory depression with pregabalin | Rare but dramatic | "My father took tilidine and Lyrica - one night he was barely breathing, the ambulance service gave naloxone." |
| Accidentally beer in the evening | Common | "I had forgotten I had taken tilidine in the morning - the beer in the evening knocked me out completely, I could barely stand." |
| Withdrawal after self-stopping | Common | "After 3 months I thought I was cured - the abrupt stopping was hell, now with a pain specialist for structured tapering." |
| Drop misuse in the family environment | Common | "My drops were suddenly empty - my son (16) had shared them for 'fun' with friends, a bad wake-up call for everyone." |
Tilidine experiences with chronic pain - how long may one take it? That is an individual decision of the pain specialist. With chronic non-cancer pain, the German LONTS guideline recommends a cautious indication and a regular review of the benefit. Typical treatment durations: acute postoperative pain days to weeks, acute back-pain flares a few weeks, chronic degenerative pain months to years (with regular pause attempts), cancer pain often lifelong. Risks of long-term therapy: tolerance development (ever higher doses for the same effect), dependence, opioid-induced hyperalgesia (a paradoxical intensification of pain by the opioids themselves), hormonal disturbances, constipation. Practically: consider an attempt to omit it every 3-6 months, to test whether the opioid is still needed.
Tilidine experiences with addiction - how do I notice that I am dependent? An honest and important question. Early warning signs: I take the tablets prophylactically before the pain, I often think about the next dose, I am afraid of "no longer having it", I go to several doctors for prescriptions. Middle stages: dose escalation beyond the medical prescription, concealing the intake from family/doctors, social activities are planned around the intake. Late stages: loss of control, use despite negative consequences, physical withdrawal symptoms with longer pauses. Important: physical habituation (withdrawal symptoms on stopping) is not the same as addiction - it also occurs with purely medical use. True addiction additionally has the psychological component (craving, loss of control). On suspicion: an honest conversation with the doctor, addiction counselling, in severe cases inpatient withdrawal - all options exist without stigma.
Tilidine vs. tramadol - which is better? Both are WHO step II opioids with similar pain relief, but with important differences. Tilidine advantages: the naloxone misuse protection, a prolonged-release form for long-term therapy without a controlled-drug prescription, well controllable. Tilidine disadvantages: drops subject to controlled-drug regulations, a higher misuse potential of the drops, liver-dependent metabolism (caution with liver damage). Tramadol advantages: not subject to controlled-drug regulations, an additional serotonergic/noradrenergic effect (good with neuropathic pain), often cheaper. Tramadol disadvantages: a serotonin syndrome risk with SSRI combination, a higher seizure risk, a higher side-effect profile (nausea). Rule of thumb: with a neuropathic-pain component tramadol, with purely nociceptive pain tilidine, with SSRI therapy rather tilidine (no serotonin syndrome risk). Both with caution with a history of addiction.
Tilidine in the rap scene - what is behind it? A sad cultural reality. Tilidine drops became, in the 2010s, a symbol of certain German rap subcultures, with massive trivialisation in songs and social media. The effect in misuse doses: euphoria, disinhibition, insensitivity to pain, an overestimation of oneself - this explains the "coolness" staging. The reality: rapid tolerance development, dependence within weeks, respiratory arrest with combinations, social and health destruction. Several artists have died from tilidine or mixed use. The authorities' reaction: in 2013 the controlled-drug status of the drops, school prevention programmes, more education. Parents should know: if tilidine is prescribed in the household (e.g. after an operation), store it safely - its availability in one's own medicine cabinet is a gateway risk.
Getting rid of tilidine constipation - what really helps? The opioid-induced constipation is the most stubborn opioid side effect and does not disappear through habituation. Basic measures (often not enough): 2-3 litres of water daily, a high-fibre diet (wholegrain, fruit, vegetables), regular exercise, prunes, linseed. Usually needed with prolonged opioid therapy: osmotic laxatives such as macrogol (well tolerated, the agent of choice), stimulants such as bisacodyl (OK in the short term), lactulose. On failure: special PAMORA agents such as naloxegol or methylnaltrexone - they specifically block the opioid receptors in the gut without cancelling the pain relief. Important: treat constipation early and prophylactically - do not wait until it is there. At the start of every opioid therapy, start straight away with macrogol.